Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.850
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
07.1525.9824.3515.221.12
Revenue Growth
--72.50%6.69%60.05%1258.57%-92.32%
Gross Profit
06.3922.9621.5513.881.12
Operating Income
-122.7-114.4-67.46-71.93-62.68-111.22
Net Income
-115.81-20.6-63.69-65.77-60.51-110.74
Earnings Per Share
-1.68-0.33-2.36-2.44-2.69-12.41
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
123.04145.747.24108.85172.56148.99
Total Debt
000.831.271.660.61
Net Cash (Debt)
123.04145.746.4107.58170.9148.38
Net Cash Growth
-46.75%213.97%-56.87%-37.05%15.17%3326.88%
Net Cash Per Share
1.782.351.724.007.5916.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-107.78-97.43-59.55-59.66-49.64-22.42
Capital Expenditures
-0-0.55-1.65-3.97-0.44-0.05
Free Cash Flow
-107.78-97.99-61.2-63.64-50.08-22.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-89.36%88.36%88.47%91.23%100.00%
Operating Margin
--1601.12%-259.62%-295.36%-411.94%-9930.09%
Pretax Margin
--288.26%-245.13%-270.04%-397.69%-9829.29%
Profit Margin
--288.26%-245.13%-270.04%-397.69%-9829.46%
FCF Margin
--1371.38%-235.55%-261.29%-329.15%-2006.16%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-15.973.002.0420.60450.54